Dearborn Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.9M | Sell |
128,402
-13,549
| -10% | -$3.01M | 1.51% | 22 |
|
|
2025
Q4 | $32.4M | Sell |
141,951
-32,095
| -18% | -$7.31M | 1.62% | 16 |
|
|
2025
Q3 | $40.3M | Sell |
174,046
-479
| -0.3% | -$97.5K | 1.89% | 12 |
|
|
2025
Q2 | $32.4M | Buy |
174,525
+2,265
| +1% | +$421K | 1.53% | 30 |
|
|
2025
Q1 | $36.1M | Sell |
172,260
-39,882
| -19% | -$7.75M | 1.73% | 15 |
|
|
2024
Q4 | $37.7M | Sell |
212,142
-2,265
| -1% | -$416K | 1.58% | 22 |
|
|
2024
Q3 | $42.3M | Sell |
214,407
-5,410
| -2% | -$1.01M | 1.72% | 14 |
|
|
2024
Q2 | $37.7M | Sell |
219,817
-2,055
| -0.9% | -$340K | 1.63% | 18 |
|
|
2024
Q1 | $40.4M | Sell |
221,872
-80,335
| -27% | -$13.8M | 1.73% | 17 |
|
|
2023
Q4 | $46.8M | Sell |
302,207
-6,443
| -2% | -$939K | 1.71% | 19 |
|
|
2023
Q3 | $46M | Buy |
308,650
+188
| +0.1% | +$27.6K | 1.81% | 13 |
|
|
2023
Q2 | $41.6M | Buy |
308,462
+438
| +0.1% | +$64.2K | 1.59% | 22 |
|
|
2023
Q1 | $49.1M | Buy |
308,024
+1,037
| +0.3% | +$159K | 1.93% | 13 |
|
|
2022
Q4 | $49.6M | Buy |
306,987
+38,376
| +14% | +$5.88M | 2% | 13 |
|
|
2022
Q3 | $36M | Buy |
268,611
+213
| +0.1% | +$30.6K | 1.59% | 26 |
|
|
2022
Q2 | $41.1M | Sell |
268,398
-337
| -0.1% | -$51.5K | 1.74% | 21 |
|
|
2022
Q1 | $43.6M | Buy |
268,735
+252,320
| +1,537% | +$36.7M | 1.65% | 21 |
|
|
2021
Q4 | $2.22M | Sell |
16,415
-474
| -3% | -$56K | 0.08% | 83 |
|
|
2021
Q3 | $1.82M | Sell |
16,889
-90
| -0.5% | -$10.3K | 0.07% | 83 |
|
|
2021
Q2 | $1.91M | Buy |
16,979
+235
| +1% | +$26.5K | 0.08% | 84 |
|
|
2021
Q1 | $1.81M | Sell |
16,744
-454
| -3% | -$48.6K | 0.08% | 84 |
|
|
2020
Q4 | $1.84M | Buy |
17,198
+2,766
| +19% | +$266K | 0.08% | 82 |
|
|
2020
Q3 | $1.26M | Sell |
14,432
-138
| -0.9% | -$13K | 0.06% | 91 |
|
|
2020
Q2 | $1.43M | Buy |
14,570
+851
| +6% | +$74.9K | 0.08% | 87 |
|
|
2020
Q1 | $1.04M | Buy |
13,719
+863
| +7% | +$73.5K | 0.06% | 87 |
|
|
2019
Q4 | $1.14M | Buy |
12,856
+31
| +0.2% | +$2.57K | 0.06% | 97 |
|
|
2019
Q3 | $971K | Sell |
12,825
-7,620
| -37% | -$522K | 0.06% | 93 |
|
|
2019
Q2 | $1.49M | Sell |
20,445
-158
| -0.8% | -$12.4K | 0.09% | 81 |
|
|
2019
Q1 | $1.66M | Sell |
20,603
-1,465
| -7% | -$120K | 0.11% | 76 |
|
|
2018
Q4 | $2.03M | Buy |
22,068
+3,089
| +16% | +$272K | 0.16% | 74 |
|
|
2018
Q3 | $1.79M | Buy |
18,979
+2,519
| +15% | +$239K | 0.13% | 76 |
|
|
2018
Q2 | $1.52M | Sell |
16,460
-258
| -2% | -$25.2K | 0.12% | 75 |
|
|
2018
Q1 | $1.58M | Sell |
16,718
-861
| -5% | -$94.6K | 0.12% | 72 |
|
|
2017
Q4 | $1.7M | Sell |
17,579
-186
| -1% | -$17.5K | 0.12% | 73 |
|
|
2017
Q3 | $1.58M | Sell |
17,765
-259
| -1% | -$19.7K | 0.12% | 72 |
|
|
2017
Q2 | $1.31M | Hold |
18,024
| – | – | 0.1% | 81 |
|
|
2017
Q1 | $1.17M | Sell |
18,024
-1,315
| -7% | -$82.7K | 0.09% | 86 |
|
|
2016
Q4 | $1.21M | Sell |
19,339
-2,305
| -11% | -$141K | 0.1% | 83 |
|
|
2016
Q3 | $1.37M | Sell |
21,644
-590
| -3% | -$38.2K | 0.12% | 84 |
|
|
2016
Q2 | $1.38M | Sell |
22,234
-100
| -0.4% | -$6.09K | 0.12% | 84 |
|
|
2016
Q1 | $1.28M | Sell |
22,334
-43,290
| -66% | -$2.41M | 0.12% | 89 |
|
|
2015
Q4 | $3.89M | Buy |
65,624
+4,264
| +7% | +$246K | 0.36% | 74 |
|
|
2015
Q3 | $3.34M | Sell |
61,360
-1,225
| -2% | -$79.7K | 0.33% | 78 |
|
|
2015
Q2 | $4.21M | Sell |
62,585
-7,167
| -10% | -$468K | 0.41% | 71 |
|
|
2015
Q1 | $4.08M | Buy |
69,752
+3
| +0% | +$181 | 0.36% | 75 |
|
|
2014
Q4 | $4.56M | Sell |
69,749
-1,200
| -2% | -$75.7K | 0.42% | 72 |
|
|
2014
Q3 | $4.1M | Buy |
70,949
+402
| +0.6% | +$22.3K | 0.4% | 76 |
|
|
2014
Q2 | $3.98M | Sell |
70,547
-397
| -0.6% | -$20.8K | 0.39% | 77 |
|
|
2014
Q1 | $3.65M | Sell |
70,944
-68
| -0.1% | -$3.44K | 0.4% | 77 |
|
|
2013
Q4 | $3.75M | Buy |
71,012
+1,597
| +2% | +$78.5K | 0.44% | 72 |
|
|
2013
Q3 | $3.1M | Sell |
69,415
-7,108
| -9% | -$315K | 0.41% | 79 |
|
|
2013
Q2 | $3.16M | Buy |
+76,523
| New | +$3.35M | 0.45% | 74 |
|
Other funds holding ABBV
VCM
VPM
Dearborn Partners's ABBV Position: Q1 2026 in Review
Dearborn Partners reduced its AbbVie (ABBV) stake by 9.5% in Q1 2026, selling an estimated $3.01M and leaving 128,402 shares worth $27.9M. The position accounts for 1.51% of the portfolio, ranked #22.
Dearborn Partners first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $49.6M in Q4 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Dearborn Partners held 128,402 shares of AbbVie worth $27.9M as of Q1 2026.
- Dearborn Partners sold 13,549 AbbVie shares in Q1 2026, an estimated $3.01M.
- AbbVie made up 1.51% of Dearborn Partners's portfolio in Q1 2026, its #22 holding.
- Dearborn Partners first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Dearborn Partners's AbbVie position peaked at $49.6M in Q4 2022.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Dearborn Partners's 13F filing for Q1 2026, filed 12 May 2026.